Amedeo Cefaliello

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World Study.

Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World Study.

Journal: Current oncology (Toronto, Ont.)

Published: May 01, 2026

Predictive biomarkers for immunotherapy response in ovarian cancer: the role of repair assisted damage detection (RADD).

Predictive biomarkers for immunotherapy response in ovarian cancer: the role of repair assisted damage detection (RADD).

Journal: Expert review of clinical pharmacology

Published: February 27, 2026

First-line immunotherapy with or without PARP inhibitors in advanced ovarian cancer: A meta-analysis including bevacizumab use, molecular status, and PD-L1 expression.

First-line immunotherapy with or without PARP inhibitors in advanced ovarian cancer: A meta-analysis including bevacizumab use, molecular status, and PD-L1 expression.

Journal: Critical reviews in oncology/hematology

Published: January 27, 2026

Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution.

Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution.

Journal: Pathologica

Published: July 08, 2025

Overcoming disease progression in advanced endometrial cancer: a clinical case of sequential therapies.

Overcoming disease progression in advanced endometrial cancer: a clinical case of sequential therapies.

Journal: Drugs in context

Published: April 13, 2025

Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.

Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.

Journal: Frontiers in oncology

Published: April 05, 2024

Ribociclib in newly diagnosed hepatitis B infection: A case report.

Ribociclib in newly diagnosed hepatitis B infection: A case report.

Journal: Frontiers in oncology

Published: March 12, 2023

Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.

Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.

Journal: Biomolecules

Published: February 04, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026